News, Links and Commentary
Saturday, January 21, 2006
PEDF Gene Therapy For Wet AMD
Researchers from Johns Hopkins University in the US have successfully injected a vector containing the gene for human pigment epithelium-derived factor (PEDF) directly into the eyes of 28 patients who have wet age-related MD. The gene therapy appeared to stop further progression of the disease. The research will be published in print in the February 2006 issue (Volume 17, Number 2) of Human Gene Therapy and can be viewed online now. Read more about the research in 'Clinical Trial on Gene Therapy for Macular Degeneration Published in Human Gene Therapy' (Mary Ann Liebert, Inc. media release at Genetic Engineering News, 17 January 2006).
Comments:
Post a Comment
